Aspen Aerogels, Inc. (NYSE:ASPN) Shares Acquired by Sanders Morris Harris LLC

Sanders Morris Harris LLC lifted its position in Aspen Aerogels, Inc. (NYSE:ASPN) by 337.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,000 shares of the construction company’s stock after purchasing an additional 27,000 shares during the period. Sanders Morris Harris LLC’s holdings in Aspen Aerogels were worth $436,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Franklin Resources Inc. grew its holdings in Aspen Aerogels by 5.3% in the third quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock valued at $815,000 after purchasing an additional 1,483 shares during the period. nVerses Capital LLC lifted its position in shares of Aspen Aerogels by 45.0% during the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after buying an additional 1,800 shares in the last quarter. Point72 Hong Kong Ltd acquired a new stake in Aspen Aerogels in the 2nd quarter valued at $84,000. Quent Capital LLC purchased a new stake in Aspen Aerogels in the 3rd quarter worth $118,000. Finally, Point72 DIFC Ltd acquired a new position in Aspen Aerogels during the second quarter worth $121,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on ASPN. Canaccord Genuity Group dropped their target price on shares of Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating on the stock in a research report on Thursday. Barclays lowered their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. HC Wainwright reissued a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. Roth Mkm lowered their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Finally, Piper Sandler reduced their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $29.11.

Aspen Aerogels Trading Down 0.6 %

Shares of ASPN opened at $12.64 on Thursday. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The firm has a 50-day moving average price of $13.63 and a 200 day moving average price of $20.37. Aspen Aerogels, Inc. has a 12-month low of $10.75 and a 12-month high of $33.15. The firm has a market capitalization of $1.04 billion, a P/E ratio of 1,265.27 and a beta of 2.14.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.